Lung cancer is no longer just one disease. For many years, we spoke about small cell and non-small cell lung cancer (NSCLC). We now know that it is very important to distinguish two different histolog...
Read morePharmaMar´s antitumor agent PM1183 significantly improves overall survival compared with standard therapy in patients with resistant/refractory ovarian cancer
Read moreLa leucemia linfoblástica aguda (ALL) es un tipo raro de cáncer sanguíneo que se trata principalmente mediante quimioterapia intensiva. Si la enfermedad es resistente al tratamiento inicial o reapa...
Read moreColon cancer development starts with the formation of benign tumours called adenomas. It is estimated that between 30% and 50% of people over 50 will develop one of these tumours. These adenomas or po...
Read moreRoger Gomis’ team, in collaboration with another two groups in IRB Barcelona’s Oncology Programme, reveal in Nature Cell Biology the genes and mechanisms that allow liver metastasis to colonize th...
Read moreCientíficos del Centro Nacional de Investigaciones Cardiovasculares (CNIC) han descubierto una posible nueva vía de tratamiento para tres tipos de leucemia, al establecer que el microambiente que co...
Read moreLa Fundación Científica de la Asociación Española contra el Cáncer (aecc) financia este proyecto que pretende identificar nuevas dianas terapéuticas y marcadores que mejoren la supervivencia y c...
Read moreThe trial at UAMS is the first time a breast cancer vaccine has been tested in humans outside of US military families. The human trial trumps research by others---from Dr. Vincent Tuohy in Cleveland t...
Read moreInvestigadores del Grupo de Biología Molecular y Celular del Instituto de Investigación Biomédica de Salamanca (IBASAL), en colaboración con el 12 de octubre, han desarrollado una nueva técnica...
Read moreUna nueva investigación plantea la posibilidad de tratamientos más eficaces para la caquexia, una profunda pérdida de grasa y músculo que ocurre en aproximadamente la mitad de todos los pacientes ...
Read moreResearchers at sarcomas research group at the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) have been tested in 19 patients a new therapeutic combinatio...
Read moreThe Catalan Institute of Oncology (ICO) and the Bellvitge Biomedical Research Institute (IDIBELL) promote the study of certain cancers in animals. Specifically, tumors caused by infectious agents such...
Read more